Arch Therapeutics to Present AC5® Advanced Wound System at
A Study of AC5® Advanced Wound System in Patients with Lower Extremity Wounds to be Featured in a Clinical Poster...
Stay updated with breaking news from Wound System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Study of AC5® Advanced Wound System in Patients with Lower Extremity Wounds to be Featured in a Clinical Poster...
New code is expected to advance commercialization efforts in doctors’ offices and other outpatient settings...
(2022-05-09 | OTCQB:ARTH) Arch Therapeutics' Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
Arch Therapeutics, a Framingham biotechnology company specializing in wound care and biosurgical devices, announced on Monday its AC5 Advanced Wound System would be added to federal contracts.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium ... Arch Therapeutics, Inc.May 10, 2021 GMT FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting the broad potential of AC5 ® Advanced Wound System in chronic and non-healing wounds at the 2021 Symposium on Advanced ...